Product Code: GVR-4-68040-739-1
Diabetes Management Supplements Market Summary
The global diabetes management supplements market size was valued at USD 7.04 billion in 2024 and is projected to reach USD 14.52 billion by 2033, expanding at a CAGR of 8.56% from 2025 to 2033. The market growth is driven by the rising prevalence of diabetes worldwide, increasing awareness about preventive healthcare, and growing adoption of nutritional supplements as an adjunct to conventional diabetes management.
Factors such as lifestyle changes, rising obesity rates, and aging populations are further contributing to higher demand for supplements to control blood sugar levels, improve insulin sensitivity, and support overall metabolic health. Moreover, innovations in formulation, expanding distribution channels including e-commerce, and greater consumer inclination toward natural and herbal supplements are expected to create significant opportunities for manufacturers over the forecast period.
Rising global prevalence of diabetes and prediabetes
One of the main drivers behind the demand in the diabetes management supplements market is the increasing global prevalence of diabetes and prediabetes. The rising burden of these conditions, caused by sedentary lifestyles, poor eating habits, and growing obesity rates, has led to a surge in patients needing long-term management options. According to global health organizations, diabetes cases are steadily rising across both developed and developing regions, making it a major public health challenge of our time. For example, data from the International Diabetes Federation shows that about 589 million adults aged 20 to 79 are currently living with diabetes. With millions more at risk of complications like cardiovascular disease, neuropathy, and kidney problems, the demand for supportive and supplementary approaches to traditional treatments has become increasingly urgent.
As a result, diabetes management supplements are increasingly being recognized as an effective adjunct to prescribed medications, helping individuals maintain blood glucose levels, improve insulin sensitivity, and reduce the risk of secondary complications. These supplements, often enriched with essential vitamins, minerals, antioxidants, and herbal extracts, offer additional metabolic support and contribute to overall well-being. The expanding diabetic and prediabetic population not only ensures a steady consumer base but also compels healthcare providers and policymakers to recommend holistic management practices, thereby driving the sustained growth of the diabetes management supplements market.
Global Diabetes Management Supplements Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global diabetes management supplements market on the basis of type, ingredients, formulation, distribution channel, and region
- Type Outlook (Revenue, USD Million, 2021 - 2033)
- Multi-ingredient Supplements
- Single-ingredient Supplements
- Ingredients Outlook (Revenue, USD Million, 2021 - 2033)
- Herbal Extracts & Botanicals
- Vitamins & Minerals
- Amino Acids & Antioxidants
- Omega-3 Fatty Acids
- Probiotics
- Others
- Formulation Outlook (Revenue, USD Million, 2021 - 2033)
- Capsules
- Tablets
- Softgels
- Powders
- Liquids
- Others
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Offline
- Pharmacies & Drug Stores
- Hypermarkets/Supermarkets
- Others
- Online
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Thailand
- Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Type
- 1.1.2. Ingredients
- 1.1.3. Formulation
- 1.1.4. Distribution Channel
- 1.2. Market Definitions
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.1.1. Rising global prevalence of diabetes and prediabetes
- 3.3.1.2. Increased awareness of nutritional interventions
- 3.4. Market Restraint Analysis
- 3.4.1. Limited clinical evidence for certain supplements
- 3.5. Business Environment Analysis
- 3.5.1. PESTEL Analysis
- 3.5.2. Porter's Five Forces Analysis
Chapter 4. Type Business Analysis
- 4.1. Type Segment Dashboard
- 4.2. Global Diabetes Management Supplements Market: Type Movement Analysis
- 4.3. Global Diabetes Management Supplements Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
- 4.4. Multi-ingredient Supplements
- 4.4.1. Multi-ingredient Supplements Market, 2021 - 2033 (USD Million)
- 4.5. Single-ingredient Supplements
- 4.5.1. Single-ingredient Supplements Market, 2021 - 2033 (USD Million)
Chapter 5. Ingredients Business Analysis
- 5.1. Ingredients Segment Dashboard
- 5.2. Global Diabetes Management Supplements Market: Ingredients Movement Analysis
- 5.3. Global Diabetes Management Supplements Market Size & Trend Analysis, by Ingredients, 2021 to 2033 (USD Million)
- 5.4. Herbal Extracts & Botanicals
- 5.4.1. Herbal Extracts & Botanicals Market, 2021 - 2033 (USD Million)
- 5.5. Vitamins & Minerals
- 5.5.1. Vitamins & Minerals Market, 2021 - 2033 (USD Million)
- 5.5.2. Amino Acids & Antioxidants
- 5.5.2.1. Amino Acids & Antioxidants Market, 2021 - 2033 (USD Million)
- 5.5.3. Omega-3 Fatty Acids
- 5.5.3.1. Omega-3 Fatty Acids Market, 2021 - 2033 (USD Million)
- 5.5.4. Probiotics
- 5.5.4.1. Probiotics Market, 2021 - 2033 (USD Million)
- 5.5.5. Others
- 5.5.5.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. Formulation Business Analysis
- 6.1. Formulation Segment Dashboard
- 6.2. Global Diabetes Management Supplements Market: Formulation Movement Analysis
- 6.3. Global Diabetes Management Supplements Market Size & Trend Analysis, by Formulation, 2021 to 2033 (USD Million)
- 6.4. Capsules
- 6.4.1. Capsules Market, 2021 - 2033 (USD Million)
- 6.5. Tablets
- 6.5.1. Tablets Market, 2021 - 2033 (USD Million)
- 6.6. Softgels
- 6.6.1. Softgels Market, 2021 - 2033 (USD Million)
- 6.7. Powders
- 6.7.1. Powders Market, 2021 - 2033 (USD Million)
- 6.8. Liquids
- 6.8.1. Liquids Market, 2021 - 2033 (USD Million)
- 6.9. Others
- 6.9.1. Others Market, 2021 - 2033 (USD Million)
Chapter 7. Distribution Channel Business Analysis
- 7.1. Distribution Channel Segment Dashboard
- 7.2. Global Diabetes Management Supplements market: Distribution Channel Movement Analysis
- 7.3. Global Diabetes Management Supplements Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
- 7.4. Offline
- 7.4.1. Offline Market, 2021 - 2033 (USD Million)
- 7.4.2. Pharmacies & Drug Stores
- 7.4.2.1. Pharmacies & Drug Stores Market, 2021 - 2033 (USD Million)
- 7.4.3. Hypermarkets/Supermarkets
- 7.4.3.1. Hypermarkets/Supermarkets Market, 2021 - 2033 (USD Million)
- 7.4.4. Others
- 7.4.4.1. Others Market, 2021 - 2033 (USD Million)
- 7.5. Online
- 7.5.1. Online Market, 2021 - 2033 (USD Million)
Chapter 8. Regional Business Analysis
- 8.1. Global Diabetes Management Supplements Market Share By Region, 2024 & 2033
- 8.2. North America
- 8.2.1. North America Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.2.2. U.S.
- 8.2.2.1. Key Country Dynamics
- 8.2.2.2. Competitive Scenario
- 8.2.2.3. Regulatory Framework
- 8.2.2.4. U.S. Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.2.3. Canada
- 8.2.3.1. Key Country Dynamics
- 8.2.3.2. Competitive Scenario
- 8.2.3.3. Regulatory Framework
- 8.2.3.4. Canada Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.2.4. Mexico
- 8.2.4.1. Key Country Dynamics
- 8.2.4.2. Competitive Scenario
- 8.2.4.3. Regulatory Framework
- 8.2.4.4. Mexico Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.3.2. Germany
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. Germany Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.3.3. UK
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. UK Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.3.4. France
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. France Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.3.5. Italy
- 8.3.5.1. Key Country Dynamics
- 8.3.5.2. Competitive Scenario
- 8.3.5.3. Regulatory Framework
- 8.3.5.4. Italy Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.3.6. Spain
- 8.3.6.1. Key Country Dynamics
- 8.3.6.2. Competitive Scenario
- 8.3.6.3. Regulatory Framework
- 8.3.6.4. Spain Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.3.7. Denmark
- 8.3.7.1. Key Country Dynamics
- 8.3.7.2. Competitive Scenario
- 8.3.7.3. Regulatory Framework
- 8.3.7.4. Denmark Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.3.8. Sweden
- 8.3.8.1. Key Country Dynamics
- 8.3.8.2. Competitive Scenario
- 8.3.8.3. Regulatory Framework
- 8.3.8.4. Sweden Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.3.9. Norway
- 8.3.9.1. Key Country Dynamics
- 8.3.9.2. Competitive Scenario
- 8.3.9.3. Regulatory Framework
- 8.3.9.4. Norway Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.4.2. Japan
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. Japan Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.4.3. China
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. China Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.4.4. India
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. India Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.4.5. South Korea
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. South Korea Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.4.6. Australia
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Australia Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.4.7. Thailand
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. Thailand Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.5.2. Brazil
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Brazil Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.5.3. Argentina
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Argentina Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.6. MEA
- 8.6.1. MEA Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.6.2. South Africa
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. South Africa Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.6.3. Saudi Arabia
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Saudi Arabia Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.6.4. UAE
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. UAE Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
- 8.6.5. Kuwait
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Kuwait Diabetes Management Supplements Market, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Strategy Mapping
- 9.3. Company Position Analysis, 2024
- 9.4. Company Profiles/Listing
- 9.4.1. Herbalife Nutrition
- 9.4.1.1. Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. Amway (Nutrilite)
- 9.4.2.1. Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. Nature's Bounty (Nestle Health Science)
- 9.4.3.1. Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. Nature's Way Products, LLC
- 9.4.4.1. Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. NOW Foods
- 9.4.5.1. Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. Swanson Health Products
- 9.4.6.1. Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. Glanbia plc
- 9.4.7.1. Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. Vegatot
- 9.4.8.1. Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. Glucose Health, Inc.
- 9.4.9.1. Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.10. Life Extension
- 9.4.10.1. Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Strategic Initiatives